<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02717780</url>
  </required_header>
  <id_info>
    <org_study_id>CER 192/15</org_study_id>
    <nct_id>NCT02717780</nct_id>
  </id_info>
  <brief_title>Short Life Agents in Balanced Anesthesia on Obstructive Sleep Apnea Syndrome</brief_title>
  <acronym>DESAT</acronym>
  <official_title>Respiratory Impact of Short Life Agents Used in Balanced Anesthesia on Patients Suffering or Suspected of Obstructive Sleep Apnea (OSA) Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Vaudois</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Vaudois</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators aim to assess the respiratory effect of short half-life agents in balanced
      anesthesia on patients suffering from non-treated or suspected obstructive sleep apnea
      syndrome (OSA) We will study the impact on OSA of a regimen of remifentanil-desflurane versus
      a regimen of fentanyl-sevoflurane. Each patient will undergo three respiratory portable
      polygraphies: the night before the surgery ; the first night following the surgery ; the
      third night following the surgery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of apnea and hypopnea events per hour of sleep (Apnea-Hypopnea index) in supine position</measure>
    <time_frame>postoperative night 1</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of obstructive apnea events</measure>
    <time_frame>postoperative night 1 and night 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of time with saturation &lt; 90%</measure>
    <time_frame>postoperative night 1 and night 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean oxygen saturation</measure>
    <time_frame>postoperative night 1 and night 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total sleep duration</measure>
    <time_frame>postoperative night 1 and night 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of time in supine position</measure>
    <time_frame>postoperative night 1 and night 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of apnea and hypopnea events per hour of sleep (Apnea-Hypopnea index) in supine position</measure>
    <time_frame>postoperative night 1 and night 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean amplitude of desaturation (AD%)</measure>
    <time_frame>postoperative night 1 and night 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of time in obstructive apnea</measure>
    <time_frame>postoperative night 1 and night 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of time in central apnea</measure>
    <time_frame>postoperative night 1 and night 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of time in mixt apnea</measure>
    <time_frame>postoperative night 1 and night 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep Apnea screening questionnaire (STOP BANG questionnaire)</measure>
    <time_frame>24h before surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep Apnea screening questionnaire (Berlin questionnaire)</measure>
    <time_frame>24h before surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep Apnea screening questionnaire (Epworth questionnaire)</measure>
    <time_frame>24h before surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep Apnea screening questionnaire (NOSAS questionnaire)</measure>
    <time_frame>24h before surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain scores (numeric rating scale, 0-10)</measure>
    <time_frame>postoperative day 0,1,2 and 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative nausea and vomiting (yes/no)</measure>
    <time_frame>postoperative day 0,1,2 and 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pruritus (yes/no)</measure>
    <time_frame>postoperative day 0,1,2 and 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opiate consumption (mg morphine)</measure>
    <time_frame>postoperative day 0,1,2 and 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of satisfaction (visual analog scale)</measure>
    <time_frame>postoperative day 3</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Sleep Apnea Syndromes</condition>
  <condition>Sleep Apnea, Obstructive</condition>
  <arm_group>
    <arm_group_label>SEVO-FENTA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients scheduled for lower limb surgery will receive a balanced anesthesia with fentanyl and sevoflurane.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DES-REMI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients scheduled for lower limb surgery will receive a balanced anesthesia with remifentanil and desflurane.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl and sevoflurane</intervention_name>
    <arm_group_label>SEVO-FENTA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remifentanil and desflurane</intervention_name>
    <arm_group_label>DES-REMI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Physical status I - III

          -  Patient scheduled to undergo lower limb orthopedic surgery

          -  Patients known for non-treated obstructive sleep apnea or suspected of having an
             obstructive sleep apnea

        Exclusion Criteria:

          -  Patients known for treated obstructive sleep apnea ;

          -  Severe respiratory disease (i.e., chronic obstructive pulmonary disease, asthma,
             pulmonary fibrosis);

          -  Severe cardiovascular disease

          -  Chronic use of opiates ≥ 30mg/j morphine eq.

          -  Chronic use of benzodiazepine

          -  Inability to consent

          -  Refusal
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric Albrecht, PD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire Vaudois</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eric Albrecht, PD, MD</last_name>
    <phone>+41795566341</phone>
    <email>eric.albrecht@chuv.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rémy Midez, MD</last_name>
    <phone>+41795566326</phone>
    <email>remy.midez@chuv.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHUV (Centre Hospitalier Universitaire Vaudois)</name>
      <address>
        <city>Lausanne</city>
        <state>Vaud</state>
        <zip>1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Albrecht, PD, MD</last_name>
      <phone>+41 79 556 63 41</phone>
      <email>eric.albrecht@chuv.ch</email>
    </contact>
    <investigator>
      <last_name>Eric Albrecht, PD, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 15, 2016</study_first_submitted>
  <study_first_submitted_qc>March 18, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 24, 2016</study_first_posted>
  <last_update_submitted>February 27, 2018</last_update_submitted>
  <last_update_submitted_qc>February 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Universitaire Vaudois</investigator_affiliation>
    <investigator_full_name>Eric Albrecht</investigator_full_name>
    <investigator_title>PD Dr</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
    <mesh_term>Desflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

